Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's Disease
Clinical trial NCT04120493 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04120493
- Sponsor
- UniQure Biopharma B.V.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-06
- Primary completion
- 2029-06-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.